
    
      This is a randomised, double blind, multi-centre, double dummy, and two-way cross-over study.

      There will be a total of three cohorts. Each cohort will be treated for two 72-hour periods
      in a cross-over design, with a 3-week washout period between treatment periods. The total
      length of participant engagement (from screening to follow-up) is 79 days.
    
  